化学
造血
小分子
激酶
癌症研究
癌症
祖细胞
药理学
生物化学
干细胞
细胞生物学
内科学
医学
生物
作者
Rebecca A. Gallego,Sujin Cho-Schultz,Matthew Del Bel,Anne‐Marie Dechert‐Schmitt,Joyann S. Donaldson,Mingying He,Mehran Jalaie,Rob Kania,Jean Matthews,Michele McTigue,Jamison B. Tuttle,Hud Risley,Dahui Zhou,Ru Zhou,Omar Ahmad,Louise Bernier,Simon Berritt,John Braganza,Zecheng Chen,Julie Cianfrogna
标识
DOI:10.1021/acs.jmedchem.4c01930
摘要
Hematopoietic progenitor kinase 1 (HPK1/MAP4K1) represents a high interest target for the treatment of cancer through an immune-mediated mechanism. Herein we present highlights of the drug discovery campaign within the lactam/azalactam series of inhibitors that yielded a small molecule (
科研通智能强力驱动
Strongly Powered by AbleSci AI